Salmon Calcitonin CAS:47931-85-1

Salmon calcitonin, a synthetic version of the hormone calcitonin, is employed in the management of various bone disorders, including osteoporosis. Osteoporosis is characterized by decreased bone density and increased susceptibility to fractures, primarily among postmenopausal women and older adults. As a therapeutic agent, salmon calcitonin acts to regulate calcium and bone metabolism. It functions by inhibiting osteoclast activity, the cells responsible for bone resorption. This mechanism helps to reduce bone loss and maintain bone density, thereby mitigating the risk of fractures. Additionally, salmon calcitonin has been shown to have analgesic effects, providing relief from bone pain associated with osteoporotic fractures. Salmon calcitonin may also be used in the management of Paget's disease, a condition marked by abnormal bone remodeling, resulting in weakened bones, deformities, and pain. By modulating bone turnover and reducing excessive bone resorption, salmon calcitonin supports the normalization of bone structure and alleviation of associated symptoms in individuals with Paget's disease. The administration of salmon calcitonin typically involves subcutaneous or intramuscular injection, allowing for consistent delivery of the medication to support bone health. Its use can complement other interventions, such as calcium and vitamin D supplementation, weight-bearing exercises, and lifestyle modifications aimed at improving bone strength and reducing fracture risk. In clinical practice, salmon calcitonin plays a valuable role in the broader management of bone health, particularly in populations at risk for osteoporosis and related bone disorders. Its ability to inhibit bone resorption and promote bone formation underscores its importance in preserving skeletal integrity and preventing fractures. Furthermore, ongoing research continues to explore the potential benefits of salmon calcitonin in additional conditions affecting bone metabolism, further highlighting its versatility as a therapeutic option in the realm of bone health and disease management.